chr8-6872396-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_005218.4(DEFB1):c.62-1570C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.486 in 151,834 control chromosomes in the GnomAD database, including 18,066 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.49 ( 18066 hom., cov: 32)
Consequence
DEFB1
NM_005218.4 intron
NM_005218.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.153
Publications
1 publications found
Genes affected
DEFB1 (HGNC:2766): (defensin beta 1) Defensins form a family of microbicidal and cytotoxic peptides made by neutrophils. Members of the defensin family are highly similar in protein sequence. This gene encodes defensin, beta 1, an antimicrobial peptide implicated in the resistance of epithelial surfaces to microbial colonization. This gene maps in close proximity to defensin family member, defensin, alpha 1 and has been implicated in the pathogenesis of cystic fibrosis. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.54 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.486 AC: 73728AN: 151714Hom.: 18056 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
73728
AN:
151714
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.486 AC: 73772AN: 151834Hom.: 18066 Cov.: 32 AF XY: 0.489 AC XY: 36267AN XY: 74220 show subpopulations
GnomAD4 genome
AF:
AC:
73772
AN:
151834
Hom.:
Cov.:
32
AF XY:
AC XY:
36267
AN XY:
74220
show subpopulations
African (AFR)
AF:
AC:
22622
AN:
41398
American (AMR)
AF:
AC:
6641
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
AC:
1372
AN:
3468
East Asian (EAS)
AF:
AC:
2254
AN:
5144
South Asian (SAS)
AF:
AC:
2218
AN:
4806
European-Finnish (FIN)
AF:
AC:
6076
AN:
10532
Middle Eastern (MID)
AF:
AC:
130
AN:
294
European-Non Finnish (NFE)
AF:
AC:
31134
AN:
67906
Other (OTH)
AF:
AC:
980
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1975
3950
5924
7899
9874
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
676
1352
2028
2704
3380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1413
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.